单位:[1]Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA[2]Univ Arkansas Med Sci, Dept Internal Med, Gene Therapy Program, Little Rock, AR 72205 USA[3]Capital Univ Med Sci, Beijing Friendship Hosp, Ctr Liver, Beijing, Peoples R China首都医科大学附属北京友谊医院[4]Chongqing Univ Med Sci, Res Inst Virus Hepatitis, Chongqing, Peoples R China[*1]Univ Arkansas Med Sci, Dept Obstet & Gynecol, Slot 518,4301 W Markham St, Little Rock, AR 72205 USA
The risk of cervical cancer, one of the most prevalent cancers in the world, is determined by two viruses. Human papillomavirus (HPV) is the main risk factor for developing cervical cancer. However, although little known, it is well substantiated that the human Parvovirus adeno-associated virus type 2 (AAV), and its encoded Rep78 protein, interacts with HPV and lowers the risk of cervical cancer. HPV also contributes to AAV inhibition by serving as a helper virus for AAV and stimulating higher AAV replication levels. Here we surveyed four HPV-16 early genes, E1, E2, E6 and E7, for their ability to increase/decrease the basal level of AAV replication in stratifying squamous epithelium (the epithelial raft culture system). It was found that the HPV-16 El, E2 and E6 genes were able to help/enhance AAV-2 replication in epithelial raft cultures. Under these conditions, with all the HPV genes being expressed from the AAV p5 promoter, E1 appeared to have the strongest enhancing effect on AAV DNA replication (Southern blot), RNA expression (RT-PCR), protein expression (Western blot) and AAV virion production (2 plate-Southern blot). Further study of E1 mutants showed that the carboxy-half of E1, the putative helicase/ATPase domain, was the main contributor of helper activity. These data are important for understanding the HPV-AAV interaction and its effect on modifying cervical cancer risk. These data also suggest the possibility that the identified HPV helper genes may be useful in the generation of recombinant (r)AAV virions for gene therapy, as rAAV is increasing in popularity for such purposes. (C) 2005 Elsevier Inc. All rights reserved.
基金:
NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA104873] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA104873] Funding Source: NIH RePORTER
通讯机构:[*1]Univ Arkansas Med Sci, Dept Obstet & Gynecol, Slot 518,4301 W Markham St, Little Rock, AR 72205 USA
推荐引用方式(GB/T 7714):
You H,Liu Y,Prasad CK,et al.Multiple human papillomavirus genes affect the adeno-associated virus life cycle[J].VIROLOGY.2006,344(2):532-540.doi:10.1016/j.virol.2005.08.039.
APA:
You, H,Liu, Y,Prasad, CK,Agrawal, N,Zhang, DH...&Hennonat, PL.(2006).Multiple human papillomavirus genes affect the adeno-associated virus life cycle.VIROLOGY,344,(2)
MLA:
You, H,et al."Multiple human papillomavirus genes affect the adeno-associated virus life cycle".VIROLOGY 344..2(2006):532-540